May 15, 2017 04:05 PM EDT
Pharma

Ake­bia adds $50M deal with Vi­for for ex­clu­sive US dis­tri­b­u­tion deal for vadadu­s­tat

John Carroll

Editor & Founder

Ake­bia keeps stack­ing up the mon­ey deals for its close­ly-watched ane­mia drug.

In the lat­est deal an­nounced af­ter the mar­ket closed Mon­day, Vi­for Phar­ma said …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times